FDA says Guillain-Barre syndrome is possible risk of Pfizer’s RSV vaccine for older adults
The FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential
Read moreThe FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential
Read moreStocks are see-sawing. As investors get jittery, BofA screened for cheaper global stocks that proved resilient during the financial crisis
Read moreThese are the stocks posting the largest moves in midday trading. Source link
Read moreThe U.K. has been beset by political and economic instability in recent months, but as the investment environment undergoes a
Read moreFor many investors and analysts, this ordeal brings back memories of the Bayer Roundup saga. Source link
Read moreNames on the move ahead of the open. Source link
Read moreHaleon becomes the world's biggest standalone consumer health business, home to brands including Sensodyne toothpaste and Advil painkillers. Source link
Read more